Maze Therapeutics MAZE
NASDAQ MAZE
$32.58 +0.13 (+0.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) EBT (2024 - 2026)

Updated

Maze Therapeutics (MAZE) recorded EBT of -$44.73 million in Q2 2026, compared with -$33.68 million a year earlier.

Analysis

Maze Therapeutics (MAZE) EBT (2024 - 2026) Analysis & Trends

On a TTM basis, Maze Therapeutics' EBT came in at -$133.59 million as of Jun 30, 2026; for FY2025, it came in at -$131.12 million.

  • Across earlier years, EBT came in at $53.4 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly EBT in data going back to Q1 2024.
  • Per Business Quant, the preceding three quarters came in at -$24.21 million (Q1 2026), -$34.57 million (Q4 2025) and -$30.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 4.28 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.80 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -653.00 Mn
10 Maze Therapeutics 1.92 Bn 434.24 Mn - -44.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.73 Mn
Mar 31, 2026 -24.21 Mn
Dec 31, 2025 -34.57 Mn
Sep 30, 2025 -30.09 Mn
Jun 30, 2025 -33.68 Mn
Mar 31, 2025 -32.79 Mn
Dec 31, 2024 -29.85 Mn
Sep 30, 2024 -25.03 Mn
Jun 30, 2024 140.78 Mn
Mar 31, 2024 -27.73 Mn
API Access

Maze Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=MAZE&period=max&api_key=YOUR_API_KEY